Vosevi: Frequently Asked Questions

On July 18, 2017 the Food and Drug Administration (FDA) approved Gilead’s HCV medication sofosbuvir/velpatasvir/voxilaprevir (400mg/100mg/100mg), brand name “Vosevi” for the re-treatment of HCV in treatment-experienced people. This single tablet medication comprises sofosbuvir (SOF), a nucleotide polymerase inhibitor, velpatasvir (VEL), an NS5A inhibitor, and voxilaprevir (VOX),…Read More

Honoring Ric Weiland: Architect of a Historic Tipping Point

By Greg Mullins on Pride Foundation Blog, June 22nd, 2017 Project Inform was fortunate to be a recipient of Ric Weiland’s generous estate for many years, which was instrumental in keeping our work thriving. We are very appreciative that Ric had remembered us and our work…Read More

Project Inform releases new report on safer consumption spaces in the U.S.

SAFER CONSUMPTION SPACES IN THE UNITED STATES: The time is right to unite for a national movement Click here for a PDF of the Report. Project Inform is pleased to release “Safer Consumption Spaces in the United States: Uniting for a National Movement.” This report stems…Read More

A Simple Guide To The GOP Health Care Bills

Here’s how they’d change Obamacare. By Alissa Scheller, Jeffrey Young (originally published on Huffington Post) Senate Republicans released their draft health care bill Thursday, unveiling a proposed rollback of Medicaid expansion and funding while ensuring hefty tax cuts for the wealthy and health care companies. Among…Read More

Senate ACA Repeal Bill Would Yank Health Care from Tens of Millions

Below is a press release the National Health Law Program (NHeLP) issued today regarding the Senate bill to repeal the Affordable Care Act and cut Medicaid funding. In Rush to Pass Legislation, Senate Republicans Have Produced a Heartless Bill to Roll Back Health Care Reforms Washington…Read More

The FDA Has Approved Generic PrEP—but Access May Remain Difficult

This article from Vice.com does an excellent job of detailing the complicated issues related to the recent FDA approval of generic Truvada for PrEP. ORIGINAL POST: https://www.vice.com/en_us/article/the-fda-has-approved-generic-prepbut-access-may-remain-difficult Experts cited complicated factors, like patient and doctor awareness and the unique way the US HIV medication market functions,…Read More

The videos from our May 22nd community panel are now available.

On May 22nd, Project Inform hosted a community forum outlining how the next four years could affect people living with and at risk for HIV/AIDS and hepatitis C. The videos from those panels are now available on our youtube channel, for you to watch or share….Read More